Необязательная аналитика продукта
С вашего разрешения мы используем ограниченную аналитику с защитой конфиденциальности, чтобы понять, какие исследовательские сценарии работают. Мы не используем рекламные трекеры или запись сеансов. Этот выбор можно изменить в настройках. Прочитайте Политику конфиденциальности.
Robert Half Inc.'s published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $3.4B | |
|---|---|---|
| P/E (forward) | 16.7x |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $6.46B | $7.24B | $6.39B | $5.80B | $5.38B | -4.5% |
| Gross profit | $2.70B | $3.09B | $2.58B | $2.25B | $2.00B | -7.2% |
| Operating income | $805.8M | $890.6M | $464.6M | $241.5M | $76.5M | -44.5% |
| Net income | $598.6M | $657.9M | $411.1M | $251.6M | $133.0M | -31.3% |
| EPS (diluted) | $5.36 | $6.03 | $3.88 | $2.44 | $1.33 | -29.4% |
| EBITDA | $797.0M | $1.05B | $467.5M | $447.0M | $276.0M | -23.3% |
| R&D | — | — | — | — | — | — |
| SG&A | $1.95B | $2.12B | $2.11B | $2.01B | $1.93B | -0.3% |
Recent company headlines from major financial publishers.
In the modal base scenario, revenue stabilizes in FY2026 at $5.31B and expands to $5.53B in FY2027. Operating margins recover from the 1.42% FY2025 trough to 2.50% in FY2026 and 4.50% in FY2027, supported by $45M in annualized cost savings. Diluted EPS reaches $1.26 in FY2026 and $1.97 in FY2027. Intrinsic fair value centers at $28.25.
In the bull scenario, enterprise clients unfreeze deferred finance, accounting, and IT transformation projects. Talent Solutions volume expands rapidly, while Protiviti delivers record revenues in technology consulting and non-financial services practices. Operating leverage on the rationalized cost structure drives EBIT margins toward historical high-single-digit levels over the forecast horizon.
| Ke ↓ / g → | 1.5% | 1.8% | 2.0% | 2.3% | 2.5% |
|---|---|---|---|---|---|
| 7.7% | $29.9 | $30.5 | $31.0 | $31.6 | $32.3 |
| 8.2% | $28.6 | $29.1 | $29.5 | $30.0 | $30.6 |
| 8.7% | $27.5 | $27.9 | $28.3 | $28.7 | $29.1 |
| 9.2% | $26.5 | $26.8 | $27.1 | $27.5 | $27.9 |
| 9.7% | $25.6 | $25.9 | $26.1 | $26.4 | $26.8 |
Upcoming earnings date and setup when available.
Рейтинг, который имело опубликованное в каждом месяце издание исследования. Рейтинг сравнивает цену на дату анализа со справедливой стоимостью; он не показывает, оправдалась ли оценка.
| Год | янв. | февр. | март | апр. | май | июнь | июль | авг. | сент. | окт. | нояб. | дек. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |